T 2424/22 (Novel Pharmaceutical Composition/NOVARTIS) of 08.04.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T242422.20250408
- Date of decision
- 8 April 2025
- Case number
- T 2424/22
- Petition for review of
- -
- Application number
- 11849974.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- NOVEL PHARMACEUTICAL COMPOSITION
- Applicant name
- Novartis AG
- Opponent name
- Generics [UK] Limited
Teva Pharmaceutical Industries Ltd. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(2)Rules of procedure of the Boards of Appeal 2020 Art 012(3)Rules of procedure of the Boards of Appeal 2020 Art 012(4)
- Keywords
- Inventive step - main request and auxiliary requests 1 to 4 (no)
Amendment to case - argument (no) - Catchword
- -
- Cited cases
- G 0002/21
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The patent is revoked.